Jiangsu Recbio Technology Co., Ltd. (HKG:2179)
Hong Kong · Delayed Price · Currency is HKD 5.14
-0.03 (-0.58%)
Jul 9, 2026, 1:47 PM HKT
Jiangsu Recbio Technology Market Cap
Jiangsu Recbio Technology has a market cap or net worth of 3.17 billion as of July 9, 2026. Its market cap has decreased by -20.93% in one year.
Market Cap
3.17B
Enterprise Value
3.48B
Revenue
14.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.14
Market Cap Chart
Since March 31, 2022, Jiangsu Recbio Technology's market cap has decreased from 12.10B to 3.17B, a decrease of -73.79%. That is a compound annual growth rate of -26.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 3.17B | 28.50% |
| Dec 31, 2025 | 2.47B | -45.80% |
| Dec 31, 2024 | 4.55B | -12.74% |
| Dec 29, 2023 | 5.22B | -56.10% |
| Dec 30, 2022 | 11.88B | -1.79% |
| Mar 31, 2022 | 12.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jacobio Pharmaceuticals Group | 3.87B |
| Guangzhou Innogen Pharmaceutical Group | 3.70B |
| Mirxes Holding Company | 3.66B |
| Qyuns Therapeutics | 3.53B |
| Shandong Boan Biotechnology | 3.22B |
| Medtide | 3.20B |
| Laekna | 3.03B |
| BioDlink International Company | 2.77B |